Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Ivax boosts immunotoxin program with new agreement

July 11, 2001

PSK evaluated in clinical trials as adjuvant immunochemotherapy in colorectal cancer

July 5, 2001

Combination therapies for certain malignancies discussed by Idec

June 29, 2001

Phase I/II bladder cancer trial shows 59% complete response rate on MCC therapy

June 26, 2001

Phase I/II trial begins for malignant melanoma vaccine

June 26, 2001

Second multicenter phase I/II trial of GVAX for NSCLC

June 22, 2001

Patient enrollment completed in phase III trial of CeaVac

June 21, 2001

MabThera monoclonal antibody approved in Japan

June 21, 2001

ImClone reaches second milestone in phase III evaluation of BEC2

June 19, 2001

Phase III comparative trial of PEG-Intron and Intron A for CML completed

June 14, 2001

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...